Literature DB >> 21811020

Neuroprotective effects of a specific multi-nutrient intervention against Aβ42-induced toxicity in rats.

Martijn C de Wilde1, Botond Penke, Eline M van der Beek, Almar A M Kuipers, Patrick J Kamphuis, Laus M Broersen.   

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia in the elderly. Substantial evidence suggests a role for nutrition in the management of AD and especially suggests that interventions with combinations of nutrients are more effective than single-nutrient interventions. The specific multi-nutrient combination Fortasyn™Connect (FC), shown to improve memory in AD, provides phosphatide precursors and cofactors and is designed to stimulate the formation of phospholipids, neuronal membranes, and synapses. The composition comprises nucleotides, omega-3 polyunsaturated fatty acids (n3 PUFA), choline, B-vitamins, phospholipids, and antioxidants. The current study explored the protective properties of FC in a membrane toxicity model of AD, the amyloid-β 1-42 (Aβ42) infused rat, which shows reduced exploratory behavior in an Open Field and impaired cholinergic functioning. To this end, rats were fed an FC enriched diet or a control diet and five weeks later infused with vehicle or Aβ42 into the lateral ventricle. Ten weeks post-infusion Aβ42-rats fed the FC diet showed increased membrane n3 PUFA and phosphatidylcholine content while they did not show the reductions in exploratory behavior or in choline acetyltransferase (ChAT) and vesicular acetylcholine transporter (VAChT) immunoreactivity that were seen in Aβ42-rats fed the control diet. We conclude that FC protects the cholinergic system against Aβ42-induced toxicity and speculate that the effects of FC on membrane formation and composition might be supportive for this protective effect. Based on these data a long-term intervention study was started in the prodromal stages of AD (NTR1705, LipiDiDiet, EU FP7).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21811020     DOI: 10.3233/JAD-2011-110635

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  12 in total

1.  Synaptogenesis: Modulation by Availability of Membrane Phospholipid Precursors.

Authors:  Mehmet Cansev
Journal:  Neuromolecular Med       Date:  2016-06-01       Impact factor: 3.843

2.  Souvenaid®: a new approach to management of early Alzheimer's disease.

Authors:  C W Ritchie; J Bajwa; G Coleman; K Hope; R W Jones; M Lawton; M Marven; P Passmore
Journal:  J Nutr Health Aging       Date:  2014-03       Impact factor: 4.075

Review 3.  Potential Neuroregenerative and Neuroprotective Effects of Uridine/Choline-Enriched Multinutrient Dietary Intervention for Mild Cognitive Impairment: A Narrative Review.

Authors:  Barry S Baumel; P Murali Doraiswamy; Marwan Sabbagh; Richard Wurtman
Journal:  Neurol Ther       Date:  2020-12-26

4.  Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.

Authors:  Jeffrey Cummings; Philip Scheltens; Ian McKeith; Rafael Blesa; John E Harrison; Paulo H F Bertolucci; Kenneth Rockwood; David Wilkinson; Wouter Wijker; David A Bennett; Raj C Shah
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial.

Authors:  Hilkka Soininen; Alina Solomon; Pieter Jelle Visser; Suzanne B Hendrix; Kaj Blennow; Miia Kivipelto; Tobias Hartmann
Journal:  Lancet Neurol       Date:  2017-10-30       Impact factor: 44.182

6.  Docosahexaenoic Acid Helps to Lessen Extinction Memory in Rats.

Authors:  Michio Hashimoto; Shahdat Hossain; Masanori Katakura; Abdullah Al Mamun; Osamu Shido
Journal:  Molecules       Date:  2018-02-18       Impact factor: 4.411

7.  Mild Cognitive Impairment with a High Risk of Progression to Alzheimer's Disease Dementia (MCI-HR-AD): Effect of Souvenaid® Treatment on Cognition and 18F-FDG PET Scans.

Authors:  Maria Sagrario Manzano Palomo; Belen Anaya Caravaca; Maria Angeles Balsa Bretón; Sergio Muñiz Castrillo; Asuncion de la Morena Vicente; Eduardo Castro Arce; María Teresa Alves Prez
Journal:  J Alzheimers Dis Rep       Date:  2019-05-03

8.  Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU).

Authors:  Vibeke M Bruinenberg; Danique van Vliet; Els van der Goot; Danielle S Counotte; Mirjam Kuhn; Francjan J van Spronsen; Eddy A van der Zee
Journal:  PLoS One       Date:  2019-03-15       Impact factor: 3.240

9.  Brain Phospholipid Precursors Administered Post-Injury Reduce Tissue Damage and Improve Neurological Outcome in Experimental Traumatic Brain Injury.

Authors:  Orli Thau-Zuchman; Rita N Gomes; Simon C Dyall; Meirion Davies; John V Priestley; Martine Groenendijk; Martijn C De Wilde; Jordi L Tremoleda; Adina T Michael-Titus
Journal:  J Neurotrauma       Date:  2018-07-25       Impact factor: 5.269

10.  36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease.

Authors:  Hilkka Soininen; Alina Solomon; Pieter Jelle Visser; Suzanne B Hendrix; Kaj Blennow; Miia Kivipelto; Tobias Hartmann
Journal:  Alzheimers Dement       Date:  2020-09-13       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.